Exploring multifaceted roles of metformin in therapeutic applications, mechanistic insights, and innovations in drug delivery systems across biological contexts: a systematic review
Abstract
Metformin, a biguanide derivative, serves as a fundamental therapeutic agent in managing type 2 diabetes mellitus (T2DM) and is gaining recognition for its wider therapeutic applications, by the United Nations Sustainable Development Goal (SDG) 2030 priorities for promoting good health (SDG 3). This systematic review investigates the diverse roles of metformin, focusing on its therapeutic applications, mechanisms of action, and advancements in drug delivery systems. Employing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) framework and an optimised search strategy within Scopus and Web of Science databases, 33 high-quality studies were identified and classified into three primary thematic domains:(1) Therapeutic Applications, emphasising metformin's role in cancer, cardiovascular diseases, neurodegenerative disorders, and polycystic ovary syndrome (PCOS); (2) Mechanisms of Action, examining key pathways such as AMP-activated protein kinase (AMPK) activation, mitochondrial respiratory chain complex I inhibition, and gut microbiota modulation; and (3) Innovations in Drug Delivery Systems, investigating advanced strategies including nanoparticles, pH-responsive hydrogels, and microneedles to enhance metformin's bioavailability, targeted delivery, and patient adherence. This review highlights the challenges of conventional metformin administration, such as gastrointestinal side effects and absorption limitations, while discussing advancements in…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.